Dermata Therapeutics, Inc. Warrant

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch DRMAW and buy or sell other stocks, ETFs, and their options commission-free!

About DRMAW

Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410. 

CEO
Gerry Proehl, MBA
CEOGerry Proehl, MBA
Employees
Employees
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2014
Founded2014
Employees
Employees

DRMAW Key Statistics

Market cap
Market cap
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
154.67
Average volume154.67
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.044
52 Week high$0.044
52 Week low
$0.007
52 Week low$0.007
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.